Gentilly, France

Renaud Vaillant

This inventor holds 8 USPTO granted patents and 6 published patent applications and 5 EPO patents. Top assignees: Cryolog S.a., Ixaka France, Alaya.bio Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renaud Vaillant. Retrieved from https://idiyas.com/inventor/renaud-vaillant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Renaud Vaillant: Pioneering Inventor from Gentilly, FR

Introduction: Renaud Vaillant is a renowned inventor hailing from Gentilly, France, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Renaud Vaillant holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Renaud Vaillant has worked with leading research institutions and multinational companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Renaud Vaillant has collaborated with top scientists, engineers, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Renaud Vaillant's passion for pushing the boundaries of what is possible through innovation continues to inspire the next generation of inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…